These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 1568219
1. Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in metastatic tumor cells. Henderson BR, Tansey WP, Phillips SM, Ramshaw IA, Kefford RF. Cancer Res; 1992 May 01; 52(9):2489-96. PubMed ID: 1568219 [Abstract] [Full Text] [Related]
2. Autocrine and paracrine regulation of tissue inhibitor of metalloproteinases, transin, and urokinase gene expression in metastatic and nonmetastatic mammary carcinoma cells. Korczak B, Kerbel RS, Dennis JW. Cell Growth Differ; 1991 Jul 01; 2(7):335-41. PubMed ID: 1782152 [Abstract] [Full Text] [Related]
3. Post-transcriptional regulation of urokinase plasminogen activator gene expression occurs in the nucleus of BC1 rat mammary tumor cells. Henderson BR, McDonald DA, Kefford RF. Int J Cancer; 1992 Apr 01; 50(6):918-23. PubMed ID: 1555891 [Abstract] [Full Text] [Related]
4. Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8 cells. Dear TN, McDonald DA, Kefford RF. Cancer Res; 1989 Oct 01; 49(19):5323-8. PubMed ID: 2504488 [Abstract] [Full Text] [Related]
5. Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells. Dear TN, Ramshaw IA, Kefford RF. Cancer Res; 1988 Sep 15; 48(18):5203-9. PubMed ID: 3136918 [Abstract] [Full Text] [Related]
6. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V. Int J Mol Med; 2008 Feb 15; 21(2):251-9. PubMed ID: 18204793 [Abstract] [Full Text] [Related]
7. Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor. Gualandris A, Presta M. J Cell Physiol; 1995 Mar 15; 162(3):400-9. PubMed ID: 7860647 [Abstract] [Full Text] [Related]
8. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. Wang W, Abbruzzese JL, Evans DB, Chiao PJ. Oncogene; 1999 Aug 12; 18(32):4554-63. PubMed ID: 10467400 [Abstract] [Full Text] [Related]
9. Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen. Besser D, Urich M, Sakaue M, Messerschmitt A, Ballmer-Hofer K, Nagamine Y. Oncogene; 1995 Dec 07; 11(11):2383-91. PubMed ID: 8570190 [Abstract] [Full Text] [Related]
10. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells. Mi Z, Guo H, Wai PY, Gao C, Kuo PC. Carcinogenesis; 2006 Jun 07; 27(6):1134-45. PubMed ID: 16474180 [Abstract] [Full Text] [Related]
11. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium. Tao Y, Bazan HE, Bazan NG. Invest Ophthalmol Vis Sci; 1996 Sep 07; 37(10):2037-46. PubMed ID: 8814143 [Abstract] [Full Text] [Related]
12. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87). Krüger A, Soeltl R, Lutz V, Wilhelm OG, Magdolen V, Rojo EE, Hantzopoulos PA, Graeff H, Gänsbacher B, Schmitt M. Cancer Gene Ther; 2000 Feb 07; 7(2):292-9. PubMed ID: 10770639 [Abstract] [Full Text] [Related]
13. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor. Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K. Int J Oncol; 2006 Apr 07; 28(4):807-14. PubMed ID: 16525628 [Abstract] [Full Text] [Related]
14. Regulation of the uPA gene in various grades of human glioma cells. Lakka SS, Bhattacharya A, Mohanam S, Boyd D, Rao JS. Int J Oncol; 2001 Jan 07; 18(1):71-9. PubMed ID: 11115541 [Abstract] [Full Text] [Related]
15. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model. Frandsen TL, Holst-Hansen C, Nielsen BS, Christensen IJ, Nyengaard JR, Carmeliet P, Brünner N. Cancer Res; 2001 Jan 15; 61(2):532-7. PubMed ID: 11212246 [Abstract] [Full Text] [Related]
16. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8. Niiya K, Shinbo M, Ozawa T, Hayakawa Y, Sakuragawa N. Thromb Haemost; 1995 Dec 15; 74(6):1511-5. PubMed ID: 8772229 [Abstract] [Full Text] [Related]
17. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. Merchan JR, Tang J, Hu G, Lin Y, Mutter W, Tong C, Karumanchi SA, Russell SJ, Sukhatme VP. J Natl Cancer Inst; 2006 Jun 07; 98(11):756-64. PubMed ID: 16757700 [Abstract] [Full Text] [Related]
18. Fibroblasts transformed by different ras oncogenes show dissimilar patterns of protease gene expression and regulation. Zhang JY, Schultz RM. Cancer Res; 1992 Dec 01; 52(23):6682-9. PubMed ID: 1423314 [Abstract] [Full Text] [Related]